〇Gakuya Takamatsu1,2, Kumiko Yanagi5, Yoko Nanome4, Kae Koganebuchi6, Junseok Lee1, Kanako Toyama1, Dimitar Dimitrov9, Minami Hasegawa4, Tomoko Hayakawa10, Kotarou Hattori7,8, Hiroshi Kunugi7,11, Tsuyoshi Kondo2, Tomoyuki Takahashi9, Hirotaka James Okano4, Ryosuke Kimura3, Tadashi Kaname5, Masayuki Matsushita1
(1.Dept of Mol Cell Physiol, Grad Sch Med, Univ of the Ryukyus, Okinawa, Japan, 2.Dept of Neuropsy, Grad Sch Med, Univ of the Ryukyus, Okinawa, Japan, 3.Dept of Hum Biol Anat, Grad Sch Med, Univ of the Ryukyus, Okinawa, Japan, 4.Div of Regen Med, Jikei Univ Sch of Med, Tokyo, Japan, 5.Dept of Gen Med, Natl Ctr for Chd Hlth Dev, Tokyo, Japan, 6.Dept of Biol Sci, Grad Sch of Sci, Univ of Tokyo, Tokyo, Japan, 7.Dept of Ment Dis Res, Natl Inst of Natl Ctr of Neur Psyc, Tokyo, Japan, 8.Med Gen Cent, Natl Ctr of Neur Psyc, Tokyo, Japan, 9.Cel and Mol Syn Func Unit, Okinawa Inst of Sci Tech Grad Univ, Okinawa, Japan, 10.Dept of Phamc, Jichi Med Univ, Tochigi, Japan, 11.Dept of Psych, Teikyo Univ Sch of Med, Tokyo, Japan)
Keywords:Bipolar disorder, patient-derived, iPS cell, mitochondria